Circulating levels of undercarboxylated and bioactive osteocalcin double during aerobic exercise at the time levels of insulin decrease. In contrast, circulating levels of osteocalcin plummet early during adulthood in mice, monkeys, and humans of both genders. Exploring these observations revealed that osteocalcin signaling in myofibers is necessary for adaptation to exercise by favoring uptake and catabolism of glucose and fatty acids, the main nutrients of myofibers. Osteocalcin signaling in myofibers also accounts for most of the exercise-induced release of interleukin-6, a myokine that promotes adaptation to exercise in part by driving the generation of bioactive osteocalcin. We further show that exogenous osteocalcin is sufficient to enhance the exercise capacity of young mice and to restore to 15-month-old mice the exercise capacity of 3-month-old mice. This study uncovers a bone-tomuscle feedforward endocrine axis that favors adaptation to exercise and can reverse the age-induced decline in exercise capacity.
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In Brief Mera et al. show that the bone-derived hormone osteocalcin is necessary for optimum exercise capacity and that this hormone decreases with aging in mice, monkeys, and humans of both genders. Osteocalcin promotes muscle uptake and utilization of glucose and lipids during exercise and greatly improves the exercise capacity of old mice.
INTRODUCTION
The ability to perform exercise is an evolutionary conserved function that has been essential for the survival of most vertebrates and nowadays has significant health benefits (Neufer et al., 2015; Zierath and Wallberg-Henriksson, 2015) . During exercise, muscle function needs to significantly increase; this requires that the uptake and catabolism of the two main nutrients of myofibers, glucose and fatty acids (FAs), markedly rise (Hawley et al., 2014) . As an anabolic hormone, insulin promotes glucose uptake in myofibers and stores it in the form of glycogen post-prandially (Saltiel and Pessin, 2002) . However, insulin does not promote glucose catabolism, and its circulating levels decline during exercise (Coderre et al., 1995; Lund et al., 1995) . This suggests that the rise in nutrient uptake and in their catabolism in muscle that occurs during exercise may be favored by other secreted molecules, myokines (Catoire and Kersten, 2015) or hormones, the circulating levels of which would increase during exercise. Conceivably, myokines and hormones may cooperate to favor adaptation to exercise.
The ability of bone to sense mechanical forces, the physical proximity of the two tissues, and the fact that exercise capacity and bone mass decline at the same time have long suggested that a crosstalk between bone and muscle may exist (Novotny et al., 2015) . The recent identification of bone-derived hormones and of their receptors allows us to test if bone regulates muscle function at rest or during exercise and to elucidate the molecular bases of this function. Another reason to ask this question arises from a feature of the bone-derived hormone osteocalcin: this hormone favors physiological functions that, like memory and male fertility, greatly decline with age (Oury et al., 2011 (Oury et al., , 2013 . This observation raises the possibility that osteocalcin may regulate other physiological processes severely affected by aging, such as muscle function during exercise (Partridge and Gems, 2002) .
In testing this hypothesis, we observed that the circulating levels of osteocalcin double during endurance exercise in young adult wild-type (WT) mice, decrease sharply before or around mid-life in all species tested, and do not increase during exercise in older mice to the same extent as in young mice. Exploring these observations revealed that osteocalcin signaling in myofibers favors adaptation to exercise in part because it promotes the uptake and catabolism of glucose and FAs. These observations explain why exogenous osteocalcin restores the exercise capacity of 15-month-old mice to that of 3-month-old mice. In addition to its regulation of nutrient uptake and catabolism, osteocalcin signaling in myofibers is also responsible for most of the exercise-induced increase in the circulating levels of interleukin-6 (IL-6), a myokine that promotes adaptation to exercise in part by increasing the production of bioactive osteocalcin. Hence, a feedforward regulation linking together the endocrine functions of bone and muscle appears to be necessary and sufficient to favor adaptation to exercise.
RESULTS

Regulation of Osteocalcin by Exercise and Age
The growing number of functions ascribed to osteocalcin (Karsenty and Olson, 2016) raises the question of whether the circulating levels of this hormone change in various physiological situations. This analysis revealed that a single bout of endurance aerobic-based exercise (40 min run on a treadmill at 30 cm/s, 80% VO 2 max, thereafter referred to as exercise) increased circulating osteocalcin levels of total, undercarboxylated, and bioactive 2-fold in 3-month-old WT mice, while at same time the circulating levels of insulin decreased. This increase in the circulating levels of bioactive osteocalcin was due in part to an increase in bone resorption, the arm of bone remodeling that is responsible for osteocalcin decarboxylation and activation (Ferron et al., 2010) (Figures 1A-1C ). Circulating osteocalcin levels also significantly increased in young women after a 45 minlong exercise ( Figure 1D ).
In contrast, circulating osteocalcin levels greatly decreased in all species tested in another physiological situation, aging. Indeed, whether we measure total or undercarboxylated circulating osteocalcin, these levels decreased by 70% in male and female mice between 2 and 9 months of age. This was due to a decline in Osteocalcin expression and in bone formation as measured by serum PINP levels ( Figures 1E-1H ). This decrease in circulating osteocalcin levels occurs at the time the ability of mice to perform exercise declines, and circulating osteocalcin levels do not increase to the same extent in 6-or 12-month-old mice as in 3-month-old mice during exercise (Figures 1I and 1J) . The same decrease in circulating osteocalcin levels was seen in male and female rhesus monkeys between young (2-3 years) and middle age (13-15 years) ( Figure 1K ). In humans, circulating osteocalcin levels reach their lowest point before 30 years old in women and 50 years old in men ( Figure 1L ).
The increase of circulating osteocalcin levels during exercise, and their decrease with age when exercise capacity declines, led us to test whether exogenous osteocalcin could increase the exercise capacity of older WT mice. In a proof-of-principle experiment, we first asked whether one intraperitoneal (i.p.) injection of uncarboxylated mouse osteocalcin (osteocalcin) (100 ng/g of body weight) immediately before exercise would improve the exercise capacity of 3-month-old WT mice. This injection raised circulating osteocalcin levels without affecting those of insulin (Figures S1A and S1B, available online) and increased the time and distance these mice run on the treadmill at a constant speed (30 cm/s) before exhaustion by over 20% ( Figure 1M ). In view of these results, 12-and 15-month-old WT mice that have low circulating osteocalcin levels were injected with osteocalcin (500 ng/g of body weight) prior to exercise. This injection increased circulating osteocalcin levels more than 4-fold and conferred to these older mice the ability to run the same time and distance as 3-month-old untreated WT mice ( Figures S1C and 1N ). Chronic delivery of osteocalcin through mini-pumps (90 ng/hour) for 28 days also increased circulating osteocalcin levels without affecting those of insulin (Figures S1D and S1E), as well as the time and distance 10-month-old WT mice run on a treadmill before exhaustion (Figure 1O) . Thus, exogenous osteocalcin is sufficient to reverse the age-induced decrease in exercise capacity in mice.
Osteocalcin Signaling in Myofibers Is Necessary for Adaptation to Exercise
The observations presented above raised the question of whether osteocalcin is necessary for adaptation to exercise. Given the influence of testosterone on physical activity and the low circulating testosterone levels in male Osteocalcin (Ocn) À/À mice, this question was addressed in female mice.
When forced to run on a treadmill at a constant speed until exhaustion, 3-, 6-, and 9-month-old Ocn À/À mice run 20% to 30% less time and distance than WT littermates (Figures 2A and S2A) . Since exercise capacity may vary even in genetically identical animals, experiments testing exercise capacity were conducted in several cohorts of control and mutant mice (n = 8-13 per group). This reflected the absence of a signaling event from bone to muscle since the same decline in exercise capacity (legend continued on next page) was observed in mice lacking Osteocalcin only in osteoblasts and post-natally ( Figure 2B ). Accordingly, this decline in exercise capacity was not observed in 2-month-old Ocn À/À mice, indicating that the osteocalcin regulation of exercise capacity is not of developmental origin ( Figure S2B ). The same decrease in exercise capacity was observed in several cohorts of 3-month-old mice lacking Gprc6a, the osteocalcin receptor (Oury et al., 2011 ) ( Figure 2C ). Ocn À/À and Gprc6a À/À mice display metabolic and/or behavioral abnormalities that make the interpretation of any phenotype linked to exercise difficult. To exclude these confounding factors and determine if osteocalcin promotes adaptation to exercise by signaling in skeletal muscle, we studied Gprc6a expression in this tissue. A qPCR survey showed that Gprc6a was more highly expressed in skeletal muscles than in most tissues, and more so in oxidative muscles (soleus) that are needed for a prolonged effort than in glycolytic muscles (EDL), and an in situ hybridization analysis demonstrated that Gprc6a is expressed in myofibers ( Figures 2D-2F ). Moreover, Gprc6a expression was 3-fold higher in Ocn À/À than in WT muscle, and osteocalcin did not increase cAMP production in Gprc6a À/À myotubes as it did in WT ones (Figures 2G and 2H) . In view of these data suggesting that Gprc6a mediates osteocalcin signal in myofibers, we deleted Gprc6a from myofibers by crossing mice harboring a floxed allele of Grpc6a with Mck-Cre deleter mice (Brü ning et al., 1998) . Gprc6a expression was decreased over 50% in skeletal muscles in Gprc6a Mck À/À mice ( Figure S2C ). Body composition, glucose tolerance, and insulin sensitivity were similar in Gprc6a Mck À/À and control mice ( Figures S2D-S2F ).
Starting at 3 months of age, all cohorts of Gprc6a Mck À/À mice experienced a decrease in exercise capacity that was of equal severity as the one noted in Ocn À/À mice ( Figure 2I ). This could not be explained by a disruption of the intrinsic properties of muscle since excitation-contraction coupling and resistance to fatigue were not lower in Gprc6a Mck À/À than in control muscles.
Fiber type composition and size were also the same in muscles of Gprc6a Mck À/À and control mice . That a similar decrease in exercise capacity was seen in compound mutant mice lacking one allele of Osteocalcin and one allele of Gprc6a in myofibers (Ocn +/À ;Gprc6a Mck +/À ) provides a genetic support to the notion that osteocalcin is the ligand of Gprc6a in myofibers that is responsible for Gprc6a regulation of adaptation to exercise ( Figure 2J ). Moreover, a single injection of osteocalcin increased the exercise capacity of Ocn À/À mice, but did not do so in Gprc6a Mck À/À mice ( Figures 2K and 2L ). At the same time, multiple evidences suggest that the ability of osteocalcin to favor adaptation to exercise is not secondary to its signaling in the heart: Gprc6a expression is 20-fold lower in the heart than in skeletal muscle ( Figure 2D ), heart function is normal in Figures S3A-S3G ). Given their negative nature, these results need to be interpreted cautiously, yet they indicate that the ability of osteocalcin signaling in myofibers to favor adaptation to exercise is not secondary to a measurable effect on mitochondrial number or function. Hence, we turned our attention to nutrient uptake and catabolism during exercise. The main nutrient used by muscle to generate energy at the onset of exercise is glucose that is stored in myofibers in the form of glycogen (Lehninger et al., 2000) . Glycogen breakdown measured by the difference between glycogen content at rest and after exercise was lower in Gprc6a Mck À/À and Ocn À/À muscle than in control ones ( Figures 3D and S3H ). In contrast, liver glycogen breakdown was the same in Gprc6a Mck À/À and control mice ( Figure S3I ). Furthermore, osteocalcin enhanced glucose uptake, as determined by the uptake of 3 H-2-deoxy-
, myotubes. The same was true in WT isolated soleus treated with osteocalcin ( Figures 3E, 3F , and S3J). In vivo, the uptake of 3 H-2DG was significantly increased in oxidative muscles in WT mice receiving osteocalcin prior to exercise but was decreased in those of Gprc6a Mck À/À mice after exercise ( Figures 3G and   3H ). Lastly, osteocalcin favored glycolysis, defined by the extracellular acidification of the media (ECAR), in WT, but not in Gprc6a À/À , myofibers ( Figure 3I ). Importantly, none of the other proposed ligands of Gprc6a favored glucose uptake or glycolysis in WT myotubes and myofibers (Figures S3K and S3L) . To promote glucose uptake in muscle osteocalcin does not affect the expression of Glut1 and Glut4 ( Figure S3M ), but rather favors the translocation of GLUT4 to the plasma membrane of C2C12 myoblasts that express Gprc6a-myc and HA-Glut4-Gfp ( Figure 3J ). Signaling through GPCRs can promote Akt phosphorylation, an event that is observed in muscles after exercise and that allows the translocation of GLUT4 to the plasma membrane (Deshmukh et al., 2006; Lopez-Ilasaca et al., 1997) . We found that Akt phosphorylation was decreased in muscles of Gprc6 Mck À/À and Ocn À/À compared to those of control mice after exercise; conversely, acute or chronic administration of osteocalcin induced Akt phosphorylation in WT myotubes and muscle ( Figures 3K and S3N-S3P ). (Exercise refers to 40 min running at 30 cm/s on a treadmill.) All data are presented as mean ± SEM.
To assess the influence of osteocalcin signaling in myofibers on the activity of the TCA cycle, we performed a metabolomics study. This analysis showed that the accumulation of aspartate, a reliable indicator of the cellular levels of the TCA cycle intermediate oxaloacetate, and of fumarate and malate, the two TCA cycle intermediates that increase the most during exercise (Gibala et al., 1998; Sahlin et al., 1990) , did not rise to the same extent in muscles of Gprc6a Mck À/À as in those of control mice after exercise ( Figures 3L-3N ). Moreover, the contribution of 13 C-glucose to the labeling of each TCA cycle intermediate measured and of lactate was decreased in muscle of Gprc6 Mck À/À mice injected with 13 C-glucose prior to exercise ( Figure 3O ). This latter result suggests that the lower content of TCA cycle intermediates in Gprc6a Mck À/À muscles after exercise reflects in part a decrease in the entry of carbon originating from glucose into the TCA cycle. This decreased uptake and catabolism of glucose in muscle of Gprc6 Mck À/À mice explains why the oxygen consumption rate (OCR) was 2-fold lower in Gprc6a
than in WT myofibers when the only nutrient of these myofibers was glucose ( Figure 3P ). The ability of osteocalcin signaling in myofibers to favor glucose uptake also provides an explanation for the increase in blood glucose levels observed in Gprc6a Mck À/À mice running until exhaustion ( Figure 3Q ).
Osteocalcin Signaling in Myofibers Favors FA Utilization during Exercise
Since FA uptake and oxidation in muscle progressively increase during exercise (Hawley et al., 2014; Koves et al., 2005) , we tested if osteocalcin signaling in myofibers also affects these processes during exercise. We first measured muscle and plasma levels of acylcarnitines, a reliable indicator of FA utilization in cells (Overmyer et al., 2015) . We found that the accumulation of long-and mediumchain acylcarnitines seen in muscles of control mice after exercise did not occur nearly to the same extent in muscles of Gprc6a Mck À/À mice ( Figure 4A ). There was instead a significant rise in acylcarnitine accumulation in the plasma of Gprc6a Mck À/À mice ( Figure 4B ). Moreover, the levels of free L-carnitine that significantly declined in muscles of control mice after exercise did not do so to the same extent in those of Gprc6a Mck À/À mice ( Figure S4A ). These results, which suggest that osteocalcin signaling in myofibers is needed for efficient FA catabolism during exercise, explain in part why osteocalcin did not increase 14 C-oleate oxidation in Gprc6a À/À myotubes as it did in WT ones, and why the OCR of Gprc6a À/À myofibers was significantly lower than that of WT ones when oleate was the only substrate of these myofibers ( Figures 4C, 4D , and S4B). Plasma non-esterified fatty acid (NEFA) levels were significantly higher in Gprc6a Mck À/À than in control mice after exercise, while glycerol levels were unchanged. These results are consistent with the notion that FA uptake and catabolism in muscle are decreased in mice lacking osteocalcin signaling in myofibers (Figures 4E and S4C) . How does osteocalcin favor FA catabolism in myofibers? Once phosphorylated at Thr172, the cellular energy sensor AMPK promotes FA utilization in muscle by increasing the activity of CPT1B, a transporter of long-chain FAs into the mitochondria (O'Neill et al., 2014) . AMPK phosphorylation at Thr172 was reduced in muscles of Gprc6a Mck À/À compared to those of control mice after exercise, and conversely, exogenous osteocalcin increased AMPK phosphorylation in muscles of WT mice during exercise (Figures 4F and 4G) . Likewise, phosphorylation of ACC (Ser79) was decreased and the accumulation of malonyl-CoA was increased in Gprc6a Mck À/À muscles after exercise ( Figures   S4D and S4E ). Osteocalcin promotes FA oxidation in muscle in an AMPK-dependent manner, since it induces FA oxidation in WT, but not Ampka2 À/À , myotubes ( Figure 4H ). In contrast, osteocalcin favored glucose uptake in an AMPK-independent manner ( Figure 4I ). Hormone sensitive lipase (HSL) favors hydrolysis of intracellular triglycerides into free FAs in muscle when phosphorylated at Ser563 (Watt and Spriet, 2010 Figures 5D-5F ). Accordingly, CREB mediates osteocalcin regulation of glucose uptake in myotubes and glycolysis in myofibers (Figures 5G and 5H) . However, the fact that osteocalcin induces FA oxidation equally well in control and Creb À/À myotubes indicates that osteocalcin uses other transcriptional mediators to favor FA oxidation ( Figure 5I ). Taken together, these results indicate that osteocalcin signaling in myofibers favors uptake and catabolism of both glucose and FAs in a balanced manner during exercise. These findings imply that osteocalcin signaling should be necessary to generate the ATP required for optimum muscle performance during exercise. In agreement with this hypothesis, ATP levels were significantly lower in muscles of Gprc6a Mck À/À mice than in those of control ones after exercise ( Figure 5J ). This low ATP content, along with the decreased phosphorylation of AMPK, suggests that osteocalcin signaling in myofibers regulates AMPK phosphorylation in part in an AMP-independent manner (Jensen et al., 2007) .
Osteocalcin Is Necessary for the Increase in Interleukin-6 Expression in Muscle Occurring during Exercise
To determine if osteocalcin signaling in myofibers favors adaptation to exercise through additional mechanisms, we performed a transcriptomic analysis in muscles of control and Gprc6a Mck À/À mice after exercise. The gene whose expression was the most decreased (80%) in Gprc6a Mck À/À muscle after exercise was the one encoding IL-6, a myokine whose circulating levels markedly rise during exercise through previously unknown mechanisms (Whitham et al., 2012 ) ( Figure 6A) . A more modest decrease of the expression of the soluble IL-6 receptor was also observed, whereas no other myokines known to influence exercise (Boströ m et al., 2012; Egan and Zierath, 2013; Heinemeier et al., 2007) were affected by the absence of osteocalcin signaling in myofibers during exercise ( Figure S6A ). We verified that Il6 and Il6ra expression was significantly lower in muscles of Gprc6a Mck À/À and Ocn À/À than in those of control mice after (Exercise refers to 40 min running at 30 cm/s on a treadmill.) All data are presented as mean ± SEM. exercise ( Figures 6B and 6C ). We also observed that the rise in circulating IL-6 levels induced by exercise in control mice was blunted in Gprc6a Mck À/À and Ocn À/À mice. Of note, IL-6 circulating levels also rise in young woman during exercise ( Figures 6D-6F) . Moreover, the decrease in circulating osteocalcin levels observed in 15-month-old WT mice provides an explanation for the modest increase in circulating IL-6 levels observed during exercise; indeed, exogenous osteocalcin partially restored circulating IL-6 levels in these mice during exercise ( Figure 6G ). These observations identify osteocalcin as a major regulator of Il6 expression in muscle and suggest that the majority of the increase in IL-6 circulating levels observed during exercise originates from muscle. The results presented above raise the important question of whether or not osteocalcin signaling in myofibers during exercise requires the presence of IL-6 in muscle or blood. In vivo, injection of a neutralizing antibody against IL-6 prior to exercise did not prevent the increase in exercise capacity induced by exogenous osteocalcin in WT mice, and exogenous IL-6 (3 ng/g of body weight) did not improve the Figures 6J-6L ). Taken together, these results show that osteocalcin signals in muscle regardless of the presence or absence of IL-6 in the general circulation or in myofibers. However, IL-6 favors adaptation to exercise through previously described mechanisms and a novel one presented below.
IL-6 Favors the Production of Bioactive Osteocalcin during Exercise
Indeed, since IL-6 has been shown to signal in bone cells (Tamura et al., 1993) , we asked whether one mechanism whereby IL-6 favors adaptation to exercise may be by favoring the production of osteocalcin by osteoblasts and/or its activation by bone resorption (Ferron et al., 2010) . In cell culture, IL-6 decreased the expression of Osteocalcin (Ocn) in osteoblasts but, more importantly, increased the expression of Rankl, a cytokine that favors osteoclast differentiation, and decreased that of Osteoprotegerin (Opg), a decoy receptor for Rankl and an inhibitor of bone resorption (Teitelbaum and Ross, 2003) (Figure 7A ). These results provide one explanation for why bone resorption and circulating levels of bioactive osteocalcin significantly increase during exercise in WT mice that have high circulating levels of IL-6 at that time, but do not do so in Il6 À/À mice ( Figures   1A-1C , 7B, and 7C). This set of experiments reveals the existence of a feedforward regulatory loop linking the production of osteocalcin in bone and the synthesis of IL-6 in muscle that appears to be necessary for the increase in muscle function during exercise.
DISCUSSION
This study reveals that osteocalcin signaling in myofibers is necessary to increase adaptation to exercise in part because it promotes the uptake and catabolism of glucose and FAs in myofibers, and in part because it increases the secretion by muscle during exercise of IL-6, a myokine that favors the production of bioactive osteocalcin ( Figure 7D ). This study also shows that osteocalcin is sufficient to reverse the decline in muscle function occurring during aging.
Osteocalcin Signaling in Myofibers Is Necessary for Adaptation to Exercise
During exercise, the uptake and catabolism of glucose and FAs in myofibers increase. The fact that insulin exerts mostly anabolic functions in muscle and that its circulating levels decrease during exercise (Saltiel and Kahn, 2001 ) implies that muscle function and thereby adaptation to exercise are regulated by other secreted factors that would stimulate glucose uptake into muscle, glycogen breakdown, and/or FA uptake and catabolism. Conceivably, the circulating levels of these factors would rise during exercise. It is precisely because its circulating levels double during exercise that we tested if osteocalcin is implicated in the regulation of adaptation to exercise. Analyzing mutant mouse strains lacking Osteocalcin and/or its receptor Gprc6a in a cell-specific manner showed that osteocalcin signaling in myofibers through Gprc6a is needed for muscle function during exercise. Cell-specific and inducible deletion of Ocn established that this function of osteocalcin reflects an influence of bone on muscle that is not of developmental origin. This function of osteocalcin is also not secondary to its signaling in the heart. Hence, by signaling through Gprc6a in myofibers, osteocalcin is a systemic regulator of the adaptation to exercise in adult mice.
Osteocalcin Favors Uptake and Catabolism of Nutrients in Muscle during Exercise
While osteocalcin does not affect in any appreciable manner muscle contractility or mitochondrial biogenesis, it favors the uptake and utilization of nutrients in myofibers during exercise in several ways. First, osteocalcin signaling in myofibers favors the breakdown of glycogen, a major source of glucose for contracting muscles during exercise. Second, it promotes the translocation of the glucose transporter GLUT4 to the plasma membrane and thereby enhances glucose uptake and glycolysis. None of the other proposed ligands of Gprc6a increased glucose uptake and glycolysis in myofibers. Third, osteocalcin signaling in myofibers increases FA uptake and catabolism. Through these combined functions, osteocalcin signaling in myofibers provides the carbon atoms necessary to promote the activity of the TCA cycle and thereby produce the ATP that is needed to increase muscle function. That osteocalcin signaling in myofibers is important mainly during exercise is consistent with the notion that the endocrine regulation of nutrient uptake and utilization in muscle differs at rest and during exercise (Egan and Zierath, 2013) . These findings do not exclude in any way the likely possibility that other molecules may contribute to the regulation of adaptation to exercise. The fact that osteocalcin signaling in myofibers increases uptake and catabolism of both glucose and FAs provides an explanation for why RER, which reflects the respective utilization of both nutrients, is not affected in Gprc6 Mck À/À mice during exercise.
A Crosstalk between Bone and Muscle Determines Adaptation to Exercise Our study also identified IL-6, a myokine whose circulating levels rise during exercise and that enhances exercise capacity (Pedersen and Febbraio, 2012) , as an osteocalcin target gene in muscle. In turn, IL-6 favors adaptation to exercise in part by signaling in bone to increase osteoclast differentiation and the generation of bioactive osteocalcin. Thus, a feedforward loop between bone and muscle promotes adaptation to exercise through at least three synergistic mechanisms: first, osteocalcin enhances the uptake and catabolism of glucose and FAs in myofibers. Second, the rise in IL-6 secretion from muscle during exercise, triggered by osteocalcin, allows for the generation of glucose and FAs (Febbraio et al., 2004; van Hall et al., 2003) . Third, IL-6, through its regulation of bone resorption, increases the production of bioactive osteocalcin ( Figure 7D ). This model does not exclude the likely possibility that osteocalcin and IL-6 favor adaptation to exercise through additional mechanisms.
Osteocalcin Signaling in Muscle Can Reverse the Age-Related Decline in Muscle Function
The fact that osteocalcin is necessary for adaptation to exercise, together with the precipitous decline of its circulating levels before midlife in all species tested, raised the question of whether osteocalcin could also be sufficient to reverse the decline in muscle function that is caused by aging. Whether administered acutely or chronically, exogenous osteocalcin increased the exercise capacity of 3-month-old WT mice and restored the exercise capacity of 9-, 12-, and even 15-monthold mice to that of 3-month-old ones. This ability of osteocalcin to reverse the age-related decline in exercise capacity in mice requires that this hormone signal in myofibers. These results identify osteocalcin signaling in myofibers as a novel and powerful means to fight the age-related decline in muscle function. Given the growing number of molecules proposed to affect muscle functions (Baskin et al., 2015) , it will be important to determine if osteocalcin synergizes with some of them to favor adaptation to exercise.
EXPERIMENTAL PROCEDURES Animal and Human Studies
Ocn À/À mice were maintained on a 129-Sv genetic background; Ocn Osb (Oury et al., 2011 (Oury et al., , 2013 . For exercise studies, all mice were trained to run on a treadmill for 3 days (10 min/day, increasing speed from 10 to 17 cm/s, and an electric shock at 1 mA to trigger running). Exercise tests were performed on mice fed ad libitum at 2-6 p.m. The day of the test, mice were acclimated to the treadmill for 5 min, followed by 10 min running at a constant speed (17 cm/s), followed by a gradual speed increase up to 30 cm/s. Then mice run either until exhaustion to determine endurance capacity, or for 40 min. A gradual speed increase test was performed to determine the maximal VO 2 during exercise: mice were acclimated to the treadmill for 5 min, followed by 1 min running at 5 cm/s, followed by a gradual speed increase (3 cm/s every minute) until exhaustion, defined as the number of times a mouse fell off onto the electric grid during 1 min out of 15. For all biochemical and metabolic analyses, blood/tissues were collected and processed either at rest or at the end of a 40 min run (30 cm/s). i.p. injections of exogenous osteocalcin or IL-6 (Sigma) were performed immediately before exercise. To neutralize IL-6, 500 mg of a neutralizing antibody (R&D, #MAB206) (Pedersen et al., 2016) was administered i.p. 1 hr before exercise. Osteocalcin was synthetized as previously described (Oury et al., 2013) . Rhesus monkeys (Macaca mulatta) were housed as described in Supplemental Information at the NIH Animal Center. All procedures and animal care were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals. Human healthy volunteers were used to assay osteocalcin (Elecsys, Roche Diagnosis) across lifespan (see Supplemental Information). Human studies were approved by local ethic comittee of Lyon University, France.
Energy Metabolism Studies
Glucose and insulin tolerance tests were performed as described (Lee et al., 2007) . Ex vivo glucose uptake in EDL and soleus muscles was measured as described (Brü ning et al., 1998) with minor modifications (see Supplemental Information). For in vivo glucose uptake, a bolus of 2-deoxy-d-[
3 H]glucose ( 3 H-2-DG) (10 mCi) was administered before running (40 min at 30 cm/s). 3 H-2-DG and 3 H-2-DG-6-P content in muscle was determined by liquid scintillation counter and normalized to muscle weight (see Supplemental Information). Glucose uptake and FA oxidation in myotubes were assayed as described (Sebastiá n et al., 2007) . GLUT4 translocation was determined by optic microscopy as described ) (see Supplemental Information). OCR and extracellular acidification of the media (ECAR) in myofibers were measured using an XF24 Seahorse analyzer (Seahorse Biosciences) (see Supplemental Information). To analyze mitochondrial function, myofibers were treated sequentially with oligomycin (10 mg/mL), FCCP (200 mM), and rotenone (0.2 mM). OCR was recorded following administration of each of them. Metabolite profiling was done at the Einstein Stable Isotope and Metabolomics Core Facility. Metabolites from freeze-clamped skeletal muscles were extracted, derivatized, and run for GC-TOFMS analysis (Qiu et al., 2014) . Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis was used to quantify glycolytic and TCA cycle metabolites . The Biocrates AbsoluteIDQ p180 kit (Wang-Sattler et al., 2012) was used to quantify acylcarnitines by LC-MS/MS in plasma and muscle (see Supplemental Information).
13
C-glucose tracer analyses were done at CASE Mouse Metabolic Phenotyping Center (see Supplemental Information). ATP was measured using commercial kit (Abcam). Ex vivo analyses of muscle contractility and resistance to fatigue were performed as detailed in Supplemental Information.
Biochemistry and Molecular Biology
Serum osteocalcin, PINP, CTX, IL-6, and insulin levels were measured using ELISA assays. Blood glucose level was measured using an Accu-Check glucometer. Cyclic AMP accumulation was measured using a commercial kit (R&D). For gene expression, 1 mg of total RNA was reverse transcribed into cDNA. qPCR analyses were performed using a SYBER green master mix (Applied Biosciences) and a CFX-Connect real-time PCR (Bio-Rad). Relative expression levels of each gene were normalized to the one of Hprt or Gapdh. The genome-wide differential expression of Gprc6a Mck À/À versus Gprc6a f/f in muscle was measured by RNA sequencing (RNA-seq) (see Supplemental Information). For western blot analyses, protein extracts were separated in 8% acrylamide/Bis-acrylamide (Bio-Rad) gels and transferred to nitrocellulose membranes that were blotted using specific antibodies. For in situ hybridization, muscles were frozen in liquid N 2 -cooled methylbutane. Samples were sectioned at 10 mm using a cryostat. In situ hybridization was performed with a DIG-labeled riboprobe. Mitochondria histomorphometry and enzyme histochemistry were performed following standard protocols (see Supplemental Information).
Cell Culture
Culture of skeletal muscle myoblasts was performed as described (Gharaibeh et al., 2008) , using 15-to 20-day-old mice. Myoblasts were differentiated into myotubes for 3-4 days in a medium containing 5% horse serum. For in vitro gene inactivation of Gprc6a and Il6, myoblasts from either WT or mutant littermate mice were isolated and differentiated into myotubes. For in vitro gene inactivation of Creb and Ampka2, floxed myoblasts were isolated from mice, then divided into two groups and infected with either empty or Cre-expressing adenovirus for 2 days (University of Iowa). Muscle fibers from flexor digitorum brevis muscle were isolated from 2-to 3-month-old WT or mutant mice. Muscles were dissociated with DMEM 2% collagenase for 2 hr at 37 C in 5% CO 2 incubator. Muscle fibers were disaggregated from the tissue using a wide bore pipet and plated on matrigel-coated plates at approximately 50% confluence (see Supplemental Information). Myofibers were used after overnight incubation. Osteoblast culture was performed as described (Ducy and Karsenty, 1995) .
Statistics
All data are presented as mean ± SEM. Statistical analyses were performed using unpaired, two-tailed Student's t test for comparison between two groups and ANOVA test for experiments involving more than two groups. For all experiments, *p % 0.05, **p % 0.005. A. Free carnitine levels in quadriceps muscles of 3 month-old Gprc6af/f and
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Supplemental Information includes Supplemental Experimental
Gprc6a
Mck -/-mice at rest and after exercise.
B.
14 C-Oleate oxidation in WT myotubes treated with vehicle, osteocalcin (Ocn) or AICAR as a positive control.
C. Plasma NEFAs levels in Gprc6af/f and Gprc6a Mck -/-mice at rest and after exercise.
D.
Western blot analyses after exercise of ACC phosphorylation (Ser79) in tibialis muscles of 3 month-old Gprc6af/f and Gprc6a Mck -/-mice.
E. Malonyl-CoA levels in quadriceps muscles of 3 month-old Gprc6af/f and
Gprc6a
Mck -/-mice after exercise.
F. Expression of Hsl in gastrocnemius muscles of 3 month-old Gprc6af/f and
Gprc6a
(Exercise refers to 40 min running at 30cm/s on a treadmill). B. Plasma IL-6 levels in 3 month-old Ocn-/-mice injected with vehicle or IL-6 immediately before running.
Supplemental Experimental Procedures
Monkeys and human studies
Healthy volunteers were used to assay osteocalcin (Elecsys, Roche Diagnosis) across lifespan. For children aged 10-18, age, body mass index (kg/m 2 ) and Tanner's stages were recorded. Children with past or present therapy with growth hormone, corticosteroids (more than 3 months), or any chronic diseases were excluded. Adult individuals were selected using the following criteria: normal body mass index, no history of smoking, fracture, diabetes, chronic diseases and anti-osteoporotic agent usage. Young adult women were non menopausal and not pregnant. Studies were approved by local ethic comity of Lyon University, France. Comparison between groups was performed using Mann-Whitney nonparametric tests and trend was assessed using logistic regression.
Rhesus monkeys (Macaca mulatta) were housed at the NIH Animal Center, Poolesville, MD. Monkeys were housed individually in standard non-human primate caging on a 12h light/12h dark cycle, room temperature 78 ± 2 degrees humidity at 60 ± 20%. All monkeys had extensive visual, auditory, and olfactory but limited tactile contact with monkeys housed in the same room. Monkeys received 2 meals per day ad libitum. Water was always available ad libitum.
Monkeys were anesthetized with either Ketamine, 7-10 mg/kg, IM or Telazol, 3-5 mg/kg, IM. Blood samples were obtained by venipuncture of the femoral vein using a vacutainer and vacuum tubes. Serum was collected and stored at -80 degrees C until assayed.
Ex vivo glucose uptake
Ex vivo glucose uptake in EDL and soleus muscle was measured previously described (Bruning et al., 1998) , with two main modifications: first, 3 H-2-deoxyglucose ( 3 H-2DG, 1.5 µCi/ml) but not 14 C-mannitol, was used. Second, EDL and soleus muscles were processed as follows to separate 3 H-2DG and 3 H-2DG-6-phosphate. EDL and soleus muscles were homogenized in 500 µl water and boiled for 10 min immediately after. After that, homogenates were spin at max speed for 10 min. 50 µl of the supernatant were added to 450 µl of water and counted in 5 ml of scintillation liquid. 400 µl were passed through an anion exchange column (AG 1-X8 resin, Bio-Rad) to remove 3 H-2DG-6-phosphate.
Column was washed with 2 ml of water and 500 µl of the eluted volume were counted in 5 ml of scintillation liquid. The difference between the total and eluted 3 H radioactivity represents 3 H-2DG-6-phosphate accumulated in the tissue.
In vivo glucose uptake
For in vivo glucose uptake, a modification of a previously described method (Howlett et al., 2013) was used with some modifications. An initial pilot experiment with a group of WT resting and WT exercising mice was performed to validate the method. Briefly, mice were injected prior to exercise with 10 µCi of 3 H-2-deoxyglucose ( 3 H-2DG) in 100 µl of 0.9% NaCl. Next, mice were placed on a treadmill and were forced to run for 40 min at a constant speed (30cm/s). After exercise, blood glucose and quadriceps muscles were collected to determine 3 H radioactivity. 3 H radioactivity in blood was similar in all mice, indicating similar systemic delivery of the tracer. To determine 3 H-2DG-6-phosphate accumulation in the tissue, muscles were processed as follows: white and red quadriceps muscles were homogenized in 1 ml of water and boiled for 10 min immediately after. After that, homogenates were spin at max speed for 10 min. 50 µl of the supernatant were added to 450 µl of water and counted in 5 ml of scintillation liquid. 900 µl were passed through an anion exchange column (AG 1-X8 resin, Bio-Rad) to remove 3 H-2DG-6-phosphate. Column was washed with 6 ml of water and 500 µl of the eluted volume were counted in 5 ml of scintillation liquid.
The difference between the total and eluted 3 H radioactivity represents 3 H-2DG-6-phosphate accumulated in the tissue.
Transfection of C2C12 myoblasts for analyses of GLUT4 translocation
The day before transfection, C2C12 myoblasts were plated in 6-well plates 10% FBS, 1% penicillin/streptomycin). 24 h after transfection cells were used for the analyses of GLUT4 translocation as previously described .
Energy metabolism in myofibers
For energy metabolism studies myofibers were isolated from flexor digitorum brevis muscle and used in all experiments after an overnight incubation in Module 1 employs a targeted metabolomics approach using the Absolute IDQ p180 kit (BIOCRATES Life Sciences AG, Innsbruck, Austria) that has proved useful in predicting disorders in fuel homeostasis (Krug et al., 2012; . For glycolytic, pentose, and TCA metabolites, chromatographic analysis prior to targeted, multiple reaction monitoring (MRM) mass spectrometric analyses, was performed using an Aquity UPLC using a Waters BEH amide 1.7 µm column 2.1 x 100 mm, and an acidic mobile phase containing an acetonitrile/water gradient, as per . Samples were bracketed in between calibration standards and linear regression was performed for quantitation.
LC/MS sample preparation. For plasma samples using module 1, 10 µl was spotted per well and processed as per kit instructions. For the skeletal muscle samples, the same extract was used for both modules 1 and 3. Approximately 50 mg of tissue was used per assays. The tissue samples were homogenized with 7 times volume of methanol (with 5mmol ammonium acetate) for the sample weight. 2 µg of internal standard (U 13 C-succinate) was added to each sample prior to homogenization, after which samples frozen in liquid nitrogen were thawed on ice, sonicated and again freeze thawed. The supernatant was used for analysis.
Gas Chromatograph-Time of Flight Mass Spectrometry (GC-TOF MS) sample
preparation. The samples were homogenized using10 fold volume to the weight of skeletal muscle tissue, with methanol containing (3 internal standards, 25µM of U 13 C-citrate, 15µM of U 13 C succinate and 150µM of heptadecanoic acid). After addition of methanol to muscle sample, the sample was homogenized, then an equal volume water was added, homogenized again, frozen in liquid nitrogen, thawed on ice, sonicated and again freeze thawed, The supernatant was used for analysis. After lyophilization, the samples were methoximized with 50 µl of methoxyamine hydrochloride (MOA, 15 mg/mL in pyridine) at 30 0 C for 90 min.
The silylation step was done with 50 µl of N,O-Bis(trimethylsilyl) trifluoroacetamide (BSTFA, containing 1% TMCS) at 70 0 C for 60 min, as per (Qiu et al., 2014) .
GC-TOF MS Analysis.
The samples were analyzed using a Water GC-TOFMS Premier (Waters, USA) in electron impact ionization (EI) mode. The samples were injected at 270 0 C with a split ratio of 10. Metabolites separation was performed on a 30-meter DB-5MS column coupled with 10-meter guard column (Agilent, USA). The initial oven temperature was set to 60 0 C and kept for 1 min, then rise to 320 0 C at a rate of 10 0 C/min and kept for 3 min. Helium was used as carrier gas at a consistent flow rate of 1ml/min. The transfer line and the source temperature were set at 250 0 C and 220 0 C, separately.
Data Analysis. A pooled quality control (QC) sample, comprised of equal amounts from all samples, was injected every 10 samples, regardless of MS method, and the multiple QC injections were used to calculate the coefficient of variation (CV = standard deviation/mean) for each metabolite. Metabolites having CVs greater than 30% were not considered accurate enough for consideration, and also 75% of all measured sample concentrations for the metabolite should be above the limit of detection (LOD). To select candidate biomarkers, principal component analysis (PCA) and Partial Least Squares Discriminant Analysis (PLS-DA) were used.
C-glucose tracer studies
The contribution of glucose oxidative metabolism was assessed using mass spectrometry and 13 C stable isotope tracer technology. The fractional contributions to the CAC, amino acids and lactate were assayed in muscle homogenates using methods as previously described (Kombu et al., 2011; Zhang et al., 2015) . This approach enables isotopically labeled metabolites to be measured with a high degree of sensitivity, following a bolus of 13 C 6 glucose tracer.
GC-MS assays.
Following homogenization and centrifugation, the supernatant fractions were decanted and reserved for measurements of concentrations and 
Concentrations of intermediates in tissue.
Muscle contractility
Contractile measurements were performed on fast twitch muscle EDL and slow twitch muscle Soleus. Both muscles were dissected from hind limbs and placed in chilled Krebs solution (in mM: 119 NaCl, 4.7 KCl, 2.5 CaCl2, 1.2 KH2PO4, 1.2
MgSO4, 20 NaHCO3, bubbled with 95% O2-5% CO2 (pH 7.4). The tendons of the muscles were tied to a force transducer (400A, Aurora Scientific) and an adjustable hook using nylon sutures. The muscles were immersed in a stimulation chamber containing the Krebs solution continuously bubbled (O 2 95/ Co 2 5%) (at 28°C). The muscle was stimulated to contract using an electrical field between two platinum electrodes (Aurora Scientific 1200A -in vitro System).
The muscle length (Lo) was first adjusted to yield the maximum force. The forcefrequency relationships were determined by triggering contraction using incremental stimulation frequencies (0.5 ms pulses at 10-120 Hz for 350 ms at supra-threshold current). Between stimulations the muscle was allowed to rest for ~1 min. Fatigability of the muscles was assessed by measuring the loss of force in response to repeated stimuli (30 Hz, 300 ms duration) at 1Hz over 10 min. After the measurements of contractile properties were completed, muscles were measured at Lo, dried to remove the buffer, and weighed. The muscle cross-sectional area was determined by dividing muscle weight by its length and tissue density (1.056 g/cm3). Force production was then normalized to the muscle cross-sectional area to determine the specific force.
Muscle Histomorphometry
For mitochondria histomorphometry, EDL and soleus muscles were fixed in 4%
PFA/2% glutaraldehyde/0.1M sodium cacodylate pH 7.3, post-fixed in 1% osmium tetraoxide and embedded in epoxy resin (Epon). Ultrathin sections (80 nm) were stained with aqueous uranyl acetate and lead citrate and examined with a JEOL 2000FX transmission electron microscope. For the determination of the cross-section area of muscle fibers, gastrocnemius muscle was fixed in 10% neutral formalin, embedded in paraffin and sectioned at 5µm. Sections were stained with hematoxylin and eosin and analyzed using the ImageJ software. For determination of muscle fiber type composition, gastrocnemius muscle was frozen in liquid N 2 -cooled methylbutane. Samples were sectioned at 10µm. SDH, ATPase and COX activity assays were performed as described (Quiat et al., 2011) . Images were analyzed using the ImageJ software.
RNASeq
RNA was extracted from each group using RNAqueous®-Micro Total RNA Isolation Kit (ThermoSci, #AM1931) and the quality of purified RNA samples was determined using a Bioanalyzer 2100 (Agilent) with an RNA Pico kit. Extracted RNA samples were amplified by Ovation® RNA-Seq System V2 (NuGEN) Kit.
Amplified cDNA was labeled with Encore biotin module Kit (NuGEN) for RNASeq applications Illumina Truseq RNA Sample Prep v2 using the LT protocol. RNA was sequenced at 30M paired 100 bp reads reads per sample on an Illumina 2500 HISeq instrument.
Bases were called with Illumina's Real Time Analysis (RTA 1.9) (Illumina, 2015b) . Adaptors were trimmed and reads were converted from BCL to Fasta format with bcl2fastq 1.8.4 (Illumina, 2015a) . Reads were mapped to the mm9 mouse genome with Bowtie2 (Langmead and Salzberg, 2012) 2.0.0-beta7 and TopHat2 2.0.4. Reads were counted with HTSeq-0.6.1p2 (Anders et al., 2015) . These data were deposited in the Gene Expression Omnibus (GEO) (Barrett et al., 2013) , Accession number, GSE75919.
Experiments were normalized with TMM (Robinson and Oshlack, 2010) .
Differential expression was estimated using Limma-Voom with weights (Law et al., 2014; Liu et al., 2015) . All of the Benjamini-Hochberg (Benjamini and Hochberg, 1995) False discovery rates (fdr) were > 0.90. However, spot checking key genes by PCR, shows that an uncorrected p≤0.02 is a reliable significance cutoff for this RNASeq experiment. 242 genes were statistically significantly differentially expressed by this cutoff.
To visualize the effect of osteocalcin signaling in myofibers on gene expression independently of the magnitude of expression of each gene, raw counts for a gene were divided by the total number of counts for that gene across samples, and then log 2 transformed. In addition, clustering of all genes which were differentially expressed with p≤0.02 and range(log 2 (normalized-counts)) ≥ 1 (46 genes) was performed ( Figure 5A ). Clustering was performed with Cluster 3.0 (de Hoon et al., 2004; Eisen et al., 1998) . The expression of each gene, and then samples, were mean centered. Both genes and samples were clustered using average-linkage clustering (Everitt et al., 2011) . The heatmaps were displayed with JavaTreeView (Saldanha, 2004) .
Statistics
All data are presented as mean ± standard error of mean. Statistical analyses were performed using unpaired, two-tailed Student's t test for comparison between two groups and ANOVA test for experiments involving more than two groups. For all experiments, * denotes P ≤ 0.05, ** P ≤ 0.005.
